Marc Tessier-Lavigne Net Worth & Insider Trades
Marc Tessier-Lavigne - Director, Agios Pharmaceuticals Inc
What is Marc Tessier-Lavigne's Net Worth?
The current estimated net worth of Agios Pharmaceuticals Inc's Director, Marc Tessier-Lavigne, is estimated to be about $144.93M . Marc Tessier-Lavigne owns about 101,009 units of Agios Pharmaceuticals Inc common stock. In the last 3 years at Agios Pharmaceuticals Inc, Marc Tessier-Lavigne has sold an estimated value of $0 worth.
What is Marc Tessier-Lavigne's Past Insider Trading?
Marc Tessier-Lavigne's largest purchase order was 55,555 units , worth over $1M on April 3, 2014. In total, Marc Tessier-Lavigne has made about 5 transactions over 3 years of their time at Agios Pharmaceuticals Inc. Marc Tessier-Lavigne usually trades in June, with the busiest year in 2014.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Marc Tessier-Lavigne
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Marc Tessier-Lavigne's' Mailing Address?
- Mailing address is 1 Dna Way South San Francisco CA 94080 CA
Agios Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Jacqualyn A. Fouse, Ph.D. | 2020 | $746,750 | - | $1,751,340 | $4,593,651 | $509,657 | $10,577 | $7,611,975 |
| Jacqualyn A. Fouse, Ph.D. | 2019 | $664,583 | - | $2,538,474 | $12,875,608 | $424,125 | $105,204 | $16,607,994 |
| Jacqualyn A. Fouse, Ph.D. | 2018 | - | - | - | - | - | - | - |
| Jonathan Biller | 2020 | $500,000 | - | - | - | $258,750 | $10,578 | $769,328 |
| Jonathan Biller | 2019 | $39,583 | $110,000 | $1,008,334 | $2,025,036 | - | $936 | $3,183,889 |
| Jonathan Biller | 2017 | - | - | - | - | - | - | - |
| Christopher Bowden, M.D. | 2020 | $515,007 | - | $618,120 | $1,508,875 | $243,341 | $9,203 | $2,894,546 |
| Christopher Bowden, M.D. | 2019 | $490,539 | - | $915,590 | $1,609,989 | $198,668 | $12,422 | $3,227,208 |
| Christopher Bowden, M.D. | 2018 | $467,141 | - | $641,025 | $1,746,517 | $262,767 | $11,280 | $3,128,730 |
| Bruce Car, Ph.D. | 2020 | $494,318 | - | $833,301 | $1,499,943 | $236,250 | $164,231 | $3,228,043 |
| Bruce Car, Ph.D. | 2019 | - | - | - | - | - | - | - |
| Bruce Car, Ph.D. | 2018 | - | - | - | - | - | - | - |
| Andrew Hirsch | 2020 | $361,234 | - | $618,120 | $1,508,875 | - | $397,893 | $2,886,122 |
| Andrew Hirsch | 2019 | $500,476 | - | $1,923,145 | $1,609,989 | $202,693 | $12,528 | $4,248,831 |
| Andrew Hirsch | 2018 | $471,329 | - | $641,025 | $1,746,517 | $265,123 | $12,864 | $3,136,858 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1439222/000119312521110205/d71514ddef14a.htm
What are Agios Pharmaceuticals Inc's Past Insider Trades?
Agios Pharmaceuticals Inc's most recent insider trade came on September 28, 2023 by Cecilia Jones who sold 2,179 units worth $54.02K . In the last 10 years, insiders at Agios Pharmaceuticals Inc have sold an estimated value of $175.46M and bought an estimated value of $173.58M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are David Schenkein, Director, Scott Biller, Chief Scientific Officer, and John Duncan Higgons, Chief Operating Officer .
AGIOS PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||